Conference 2017

The 2017 conference took place from 3-5 November 2017 at Eastwood Hall, Nottingham.

Where linked click title for podcast and name for PDF of slides

Plenary session

  • The state of child health in the UK 2017 – Dr Guddi Singh, Paediatric Registrar and Advocacy Lead, British Association of Child and Adolescent Public Health (BACAPH)
  • 1/2 a percent a year – the goal of cystic fibrosis respiratory care Andrew Prayle, Clinical Assistant Professor, Child Health, Obstetrics and Gynaecology, The University of Nottingham
  • Acute kidney injury in children Dr Andrew Lunn, Consultant Paediatric Nephrologist, Nottingham University Hospitals NHS Trust
  • Paediatric TPN standardisation Anthony Lewis, Clinical Board Pharmacist for Children and Women, Pharmacy Department, University Hospital of Wales
  • NPPG regional groups Andrew Wignell, Specialist Clinical Pharmacist (PICU/Paediatric Nephrology/Teaching), Nottingham University Hospitals NHS Trust
  • Where does RPS see hospital pharmacy going? Aamer Safdar, Member, RPS Board England and Principal Pharmacist Lead for Education and Development, Guy’s and St Thomas’
    NHS Foundation Trust

Where linked click the title for a pdf of the slides and presenter name for podcast

Parallel sessions

  • Prevention and management of bronchiolitis: Where are we now? Dr Kelechi Ugonna, Consultant in Paediatric Respiratory Medicine, Sheffield Children’s Hospital NHS Foundation Trust
  • Dose adjustment in renal impairment Andrew Wignell, Specialist Clinical Pharmacist (PICU/Paediatric Nephrology/Teaching), Nottingham University Hospitals NHS Trust
  • Cystic Fibrosis alchemy – getting it right, keeping it safe Sarah Popple, Senior Pharmacist Paediatric Cystic Fibrosis – Leicester Childrens Hospital, University Hospitals Leicester
  • Enteral feeding tubes – issues in medicines management Jen Smyth, Critical Care Pharmacist & Editor of The NEWT Guidelines, Wrexham Maelor Hospital
  • Practicalities of drug administration in infants and children Judith Martin, Medication Safety Pharmacist and Dave Walker, Medication Safety Officer, Alder Hey Children’s Hospital

Short papers in the spotlight
Where linked click the title for the online Archives of Disease in childhood abstract and presenter name for pdf abstract of the slides

Where linked click name for PDF of slides

  • Publishing your work Dr Hayley Wickens, Consultant Pharmacist Anti-infectives, University Hospital Southampton NHS Foundation Trust
  • Adolescent health and relationship with medicines Octavio Aragon Cuevas, Lead Paediatric Rheumatology and Medical Specialties Pharmacist, Alder Hey Children’s NHS Foundation Trust & Paediatric Specialist Teacher Practitioner at Liverpool John Moores University
  • Neonatology for beginners Fiona Robertson, Specialist Clinical Pharmacist – Neonatology, Nottingham University Hospitals NHS Trust
  • Rheumatology in paediatrics David Harris, Principal Pharmacist, Women’s and Children’s Division, Leicester Childrens Hospital

Click the poster number where linked to view a pdf of the poster and the title for a link to the online Archives of Disease in Childhood abstract

P01 A retrospective observational study of the use of rasburicase within a tertiary paediatric oncology centre Jane Hutchinson, Bristol Royal Hospital for Children
P02 An audit of vancomycin dosing in the neonatal units Penny Fletcher, Imperial College Healthcare NHS Trust
P03 An evaluation of medication errors in paediatric cytotoxic chemotherapy, prior to electronic prescribing implementation Jenni Hatton, Nottingham Children’s Hospital
P04 Exploring the competency assessment required for pharmacists to undertake systemic anti-cancer therapy verification in paediatric haematology oncology Claire Guerin
P05 A service review of the palivizumab outpatient RSV prophylaxis clinic Michael Mitchell, NHS Greater Glasgow & Clyde
P06 A study to assess the effectiveness of Vitamin D supplementation in paediatric cystic fibrosis patients Nanna Christiansen, Barts Health NHS Trust
P07 Development of a decision-making tool to aid implementation of the national guideline on extended- interval gentamicin in neonates Ruth Hodgins, Sligo University Hospital
P08 Does the neonatal continuous intravenous infusion prescription chart reflect the medication the baby is actually receiving? Louise Whitticase, Birmingham Women’s and Children’s NHS Foundation Trust
P09 “There’s no place like home”: Reducing paediatric discharge steps Catherine Collins, Northern Health and Social Care Trust
P10 Evaluation of existing line-locking practice in central venous catheters of paediatric patients on home parenteral nutrition Amy Tustin, Newcastle upon Tyne Hospitals NHS Foundation Trust
P11 Extravasation of drugs in children – an analysis of a voluntary incident reporting system Joanna Williams, Birmingham Women’s and Children’s NHS Foundation Trust
P12 Factors affecting intravenous fluid bolus administration in paediatrics Grace Allport, University of Manchester Medical School
P13 Medication use and excipient exposure in paediatrics in a secondary care setting Hilary Brennan, Altnagelvin Hospital
P14 Pioneering use of brincidofovir to treat Adenovirus infection in a paediatric patient post bone marrow transplant Poonam Lumb, Imperial College Healthcare NHS Trus
P15 Eculizumab treatment for a paediatric stem cell transplant (SCT) patient diagnosed with transplant- associated thrombotic microangiopathy (TMA) Poonam Lumb, Imperial College Healthcare NHS Trust
P16 Pharmacist prescribing in neonatal intensive care units in the UK: An update Peter Mulholland, Royal Hospital for Children
P17 Pharmco-stability of plasma-lyte 148 and plasma-lyte 148 % glucose 5% with frequently used infused therapeutic agents Andrew Wignell, Nottingham Children’s Hospital
P18 Plasma-lyte 148 vs 0.9% saline for fluid resuscition in children: Electrolytic and clinical outcomes Andrew Wignell, Nottingham Children’s Hospital
P19 Clinical pearl: Pharmaceutical management of siblings with Guanidinoacetate Methyltransferase (GAMT) deficiency William Batten, University Hospitals Bristol NHS Foundation Trust
P20 Stability study of a mixed system of sodium benzoate and sodium phenylbutyrate in intravenous (IV) infusion fluids William Batten, University Hospitals Bristol NHS Foundation Trust
P21 Prescribing Ivacaftor in paediatric patients with Cystic Fibrosis(CF) in accordance with the clinical commissioning policy in an NHS trust Eimear Mc Geehan, Bristol Royal Hospital for Children
P22 Reducing the time that short stay surgical patients wait for discharge medication Lucy Wheeler, Cardiff & Vale UHB
P23 Reducing inpatient prescribing errors in paediatric cystic fibrosis patients: A multi-disciplinary quality improvement project Emily Bayliss, The Newcastle upon Tyne Hospitals NHS Foundation Trust
P24 Developing a pediatric electronic prescribing system Yusuf Asif, Birmingham Children’s Hospital
P25 Thalidomide administration through a nasogastric tube Yusuf Asif, Birmingham Children’s Hospital
P26 An audit of the use of amikacin for early onset sepsis in premature neonates in a UK hospital trust Caroline Dalton, Imperial College Healthcare NHS Trust
P27 Impact of new vancomycin dosing and monitoring guideline Judith Martin, Alder Hey Childrens NHS Foundation Trust
P28 Reducing medication errors – a tripartite approach. Small steps – better outcomes Bhavee Patel, Morriston Hospital, ABMU Health Board
P29 An evaluation of the views of adolescent patients with a learning disability and their carers on a medicines information leaflet Joanne Crook, Chelsea and Westminster Hospital Foundation Trust
P30 Prescribing in obese and overweight children Lucy Storey, University of Manchester
P31 Compatibility of sildenafil citrate with noradrenaline and vasopressin during simulated Y-site administration Fatemah Alsalman, Royal College of Surgeons in Ireland
P32 Rate of paediatric inpatient and discharge medication prescribing errors Joanne Crook, Chelsea and Westminster Hospital Foundation Trust
P34 Quality improvement project aimed at reducing gentamicin errors in neonates Heather Calvert, Lancashire Teaching Hospitals NHS Foundation Trust
P35 An experience of switching paediatric inflammatory bowel disease patients on infliximab therapy to the biosimilar ‘Remsima’ Mary Healy, Chelsea and Westminster Hospitals NHS Trust
P36 Streamlining the paediatric pharmacy rheumatology methotrexate monitoring and prescription service Alice Lo, Barts Health NHS Trust
P37 Audit on the quality of documentation of paediatric prescriptions using electronic prescription charts Abimbola Sanu, University College London Hospital
P38 Audit to assess Influenza Vaccination uptake amongst asthmatic children in a city in the North-West of England Octavio Aragon (Lead Pharmacist, Alder Hey)
Elisha King (LJMU Pharmacy student), Charles Morecroft (Professor of Pharmacy Practice) Alder Hey Children’s NHS Foundation Trust in collaboration with Liverpool John MooresUniversity
P39 Continuous vancomycin dosing: An audit and evaluation Fiona Robertson, Nottingham University Hospitals NHS Trust
P40 Impact of an educational intervention program on handwritten prescription errors in a paediatric critical care unit Emily Siu, Barts Health NHS Trust
P41 An audit of the screening and treatment of uveitis in children with Juvenile Idiopathic Arthritis (JIA) at a paediatric tertiary centre Amy Roughly, Liverpool John Moores University.
P42 The impact of a change to hospital guidelines on prescribing practices of nebulised 3% w/v hypertonic saline Dairmid Semple Pharmacy Department OLHC

Click here to see how the conference unfolded on Twitter

error: Content is protected !!

START TYPING AND PRESS ENTER TO SEARCH